Cutaneous metastatic disease.
The relative frequencies of cutaneous metastases are similar to those of the primary cancers; breast, colon, and melanoma are the most frequent in women and lung, colon, and melanoma are the most common in men. Cutaneous metastases represent an opportunity to detect a potentially treatable cancer before other evidence of it is present, to modify therapy as appropriate to the tumor stage, or possibly to use the cutaneous lesion as a source of easily accessible tumor cells for specific therapy. Cutaneous metastatic disease as the first sign of internal cancer is most commonly seen with cancer of the lung, kidney, and ovary.
Schwartz
R A
RA
New Jersey Medical School, Newark 07103-2714, USA.
D001943:Breast Neoplasms / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000556:secondary; D004067:Digestive System Neoplasms / Q000473:pathology; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology; D007938:Leukemia / Q000473:pathology; D008223:Lymphoma / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000556:secondary; D008654:Mesothelioma / Q000556:secondary; D009447:Neuroblastoma / Q000556:secondary; D011379:Prognosis; D012142:Respiratory Tract Neoplasms / Q000473:pathology; D012509:Sarcoma / Q000556:secondary; D012878:Skin Neoplasms / Q000453:epidemiology / Q000556:secondary* / Q000628:therapy; D014565:Urogenital Neoplasms / Q000473:pathology